Form D · Other Health Care
BIOflex Technologies Inc
Montreal, A8 · CIK 0001651728
Offering snapshot reported Aug 31, 2015 · SEC filing
- Reported sold
- $59K Offering amount: $138K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2015 | Initial | $58,950 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-246683
Total Offering Amount represents the price of the units (685,022 units @ C$0.1125 each), plus the aggregate exercise price of the warrants forming part of the units (685,022 warrants @ C$0.15 each), converted to US$.
Source: Form D, filed Aug 31, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wayne Cockburn | Director, Executive |
| Andre Godin | Director |
| Kosta Kostic | Executive |
| Leena Lakdawala | Director |
| G. Michael Newman | Director |
| William Waks | Executive |
| Charles Zablotsky | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1000 Sherbrooke Street West, Suite 2700
Montreal, A8, H3A 3G4
Montreal, A8, H3A 3G4